Japan Silent Heart Attack Market was valued at USD 0.4 Billion in 2022 and is projected to reach USD 0.7 Billion by 2030, growing at a CAGR of 8.1% from 2024 to 2030.
Japan's silent heart attack market is experiencing significant growth, propelled by an aging population and advancements in medical technology. Silent heart attacks, or silent myocardial infarctions (SMIs), occur when blood flow to a part of the heart is blocked for an extended period, leading to tissue damage without noticeable symptoms. This stealthy nature often results in delayed diagnoses, increasing the risk of severe complications such as heart failure and sudden cardiac arrest.
The market is projected to expand at a compound annual growth rate (CAGR) of approximately 7.2% during the forecast period. This growth is largely attributed to Japan's demographic trends; in 2019, about 27% of the 126 million population was aged 65 and above. With projections indicating a decrease to 124 million by 2025, the proportion of elderly citizens is expected to rise, further elevating the prevalence of SMIs.
Key segments within the market include:
Diagnosis: Techniques such as electrocardiography (ECG), magnetic resonance imaging (MRI), computed tomography (CT) scans, echocardiography, and blood tests are utilized to detect SMIs.
Treatment: Options encompass medications and surgical procedures like angioplasty and bypass surgery, aimed at restoring blood flow to the heart.
End-User: Hospitals, clinics, and ambulatory surgical centers (ASCs) are primary settings for the diagnosis and treatment of SMIs.
Several factors are driving the market's expansion:
Technological Innovations: Advanced diagnostic tools and home monitoring systems have led to a 90% reduction in inappropriate shocks and a 73% decrease in related hospitalizations in Japan.
Aging Population: The increasing number of elderly individuals contributes to a higher incidence of SMIs, thereby boosting demand for diagnostic and treatment services.
Government Initiatives: Policies aimed at enhancing cardiovascular health awareness and improving healthcare infrastructure support market growth.
Major industry players, including AstraZeneca PLC, Bayer AG, Terumo Corp., F. Hoffmann-La Roche Ltd., OrbusNeich Medical Technologies, and GlaxoSmithKline Plc, are actively involved in the market. Their strategies encompass new product launches, mergers and acquisitions, collaborations with government entities, and investments in technological advancements to maintain competitiveness.
In summary, Japan's silent heart attack market is evolving rapidly, influenced by demographic shifts and continuous medical innovations. The collaborative efforts of healthcare providers, industry stakeholders, and government bodies are essential to address the challenges posed by SMIs and to capitalize on the opportunities within this expanding market.
Get an In-Depth Research Analysis of the Japan Silent Heart Attack Market Size And Forecast [2025-2032]
AstraZeneca PLC
Hoffmann-La Roche Ltd.
Boehringer Ingelheim GmbH
Terumo Corp.
Siemens AG
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Silent Heart Attack Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Silent Heart Attack Market
Myocardial Infarction (MI)
Non-ST-Elevation Myocardial Infarction (NSTEMI)
ST-Elevation Myocardial Infarction (STEMI)
Electrocardiogram (ECG)
Blood Tests (Cardiac Biomarkers)
Imaging (CT Scan, MRI)
Age
Hypertension
Diabetes
Obesity
High Cholesterol
Smoking
Pharmacological Treatment
Non-Pharmacological Treatment
Surgical Treatment
Hospitals
Cardiac Care Units
Home Care Settings
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Silent Heart Attack Market Research Analysis
1. Introduction of the Japan Silent Heart Attack Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Silent Heart Attack Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Silent Heart Attack Market, By Type
6. Japan Silent Heart Attack Market, By Application
7. Japan Silent Heart Attack Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Silent Heart Attack Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/